BioMed Realty, one of the biggest labspace owners in the Boston area, recently acquired 215 First St., 150 Second St. and 11 ...

The two largest leases in Boston-Cambridge's life science market went to Korro Bio and Ultragenyx Pharmaceuticals, which ...

Atalanta Therapeutics is building on the growing attention around RNAi-based medicines with its $97 million Series B financing and plans to enter the clinic.

ISELIN, N.J., Jan. 31, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United ...

This evening and early part of the night will be dry with clear skies. It will turn cloudier after midnight with spells of rain pushing in from the north-west, which will be heavy in places ...

Cultivating long-term transformation MCCPDC offers many of the most utilised or high-cost generic medications, and it continues to add to its offering monthly. Garnering partners is a big part of ...

Alchemab Therapeutics has entered a collaboration with Lilly to discover novel therapeutic candidates to treat amyotrophic lateral sclerosis (ALS). Alchemab was founded in 2019 with seed funding from ...

Dyne Therapeutics Inc. 4.43% $1.38B ...

After hours: January 30 at 6:22:23 PM EST Loading Chart for CLDX ...

Sanofi S.A. Part Cert-1.97% €8.03M ...